Dialysis. Infection due to central venous catheter
Conditions
Interventions
Intervention 1: Intervention group: Daily consumption of a 40 mg Atorvastatin tablet of Soban Daru company, along with a placebo aspirin tablet, from the day of catheter placement until 6 months or ca
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Candidate patients for central venous catheterization, for whom a tunneled catheter will be implanted. Surgery performed by a surgeon and resident Consent to participate in the study
Exclusion criteria
Exclusion criteria: History of coagulopathy Existence of high blood pressure at the same time as diabetes Presence of fatty liver and liver disease based on confirmation by liver enzyme test The presence of a disease that has contraindications for taking aspirin (such as nasal polyp disease, asthma, allergy to aspirin)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of catheter operation. Timepoint: The beginning of the intervention until 180 days later. Method of measurement: checklist.;Incidence of catheter infection. Timepoint: After the intervention. Method of measurement: checklist.;Occurrence of thrombosis. Timepoint: After the intervention. Method of measurement: Clinical examination and ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| 180 days operation. Timepoint: After the intervention. Method of measurement: Checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Reza Shojaei
Arak University of Medical Sciences
Outcome results
None listed